Form 4 for VVOS Vivos Therapeutics, Inc.
Accepted 2026-08-26 16:10:16 ET · period of report 2026-07-31 · accession 0001493152-26-040238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-26 16:10 | 2026-07-31 | VVOS | Amman Bradford K. | Principal Accounting Off | A - Grant | $0.41 | +250.0K | 250.1K | +312,500% | +$102.5K |
| D | 2026-08-26 16:10 | 2026-07-31 | VVOS | Amman Bradford K. | Principal Accounting Off | A - Grant | $0.41 | +150.0K | 326.5K | +85% | +$61.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-31 | A | A | 250,000 | $0.41 | 250,080 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-07-31 | A | A | 150,000 | $0.41 | 326,533 | D | $0.41 · — to 2036-07-31 | 150,000 Common Stock | (F1) On July 31, 2026 (the "Grant Date"), the Reporting Person received a grant of 150,000 stock options, which grant was made under the Issuer's 2024 Omnibus Equity Incentive Plan. Stock options shall vest and become exercisable at the rate of 25,000 shares per month from November 1, 2026 through April 1, 2026. |